Ensuring Continuous Endpoint Protection in a Regulated Lab Environment
Successfully navigating antivirus migration in a highly regulated environment with zero downtime
CLIENT
Global Life Sciences
FOCUS AREA
Operational IT Changes
SCOPE
Antivirus Rollout
TOOLS
Tracker, Documentation, Protocols
A Controlled Transition
A global pharmaceutical company operating under strict regulatory oversight, faced an urgent need to replace its expiring antivirus software across laboratory PCs. To maintain continuous endpoint protection and meet evolving regulatory expectations for data integrity and cybersecurity, the organization initiated a controlled transition to a modern, compliant antivirus solution, aligned with internal IT policies and external compliance standards needed to transition its laboratory PC infrastructure from a soon-to-be-expired antivirus solution to a modern, compliant endpoint protection solution. This change was driven by both internal IT security policies and evolving regulatory expectations for data integrity, system validation, and cybersecurity in GxP environments.
Failure to execute this transition in a controlled, traceable, and compliant manner could have resulted in audit findings, data integrity risks, and potential disruptions to critical lab operations.
CHALLENGES
Regulated Lab Environment
The PCs were used in validated lab settings, meaning any software changes, including antivirus updates, required strict documentation, change control, and minimal disruption to validated workflows.
Documentation Burden
Every step of the process, from uninstallation to validation of the new software, had to be meticulously documented to meet internal QA standards and external regulatory scrutiny.
Lack of Standardised Procedures
The existing antivirus uninstallation and installation processes varied across sites and systems, increasing the risk of inconsistent implementation and audit findings.
Time Sensitivity
The transition needed to be completed within a tight timeline, as the existing antivirus software was approaching expiration. It was critical to ensure that all lab PCs remained continuously protected by antivirus software throughout the process, avoiding any gaps in endpoint security.
SOLUTION
To address the challenges of transitioning antivirus software in a GxP-compliant environment, IRLCA implemented a structured, transparent, and minimally disruptive rollout process. The approach was designed to ensure continuous endpoint protection, maintain lab productivity, and meet documentation and audit-readiness standards.
Key Elements of the Solution Included:
Comprehensive PC Inventory Creation
An initial inventory was developed to capture all lab PCs, including key attributes such as location, lab name, instrument type, system specifications, and current antivirus status. This ensured full visibility into the scope of the project and helped identify out-of-scope systems early.
Status-Based Workflow Management
Each PC was assigned a status at every stage of the antivirus transition, allowing the team to quickly identify bottlenecks, prioritize troubleshooting, and ensure no system was left unprotected during the transition.
Proactive Lab Communication and Scheduling
To minimise disruption to lab operations, the team coordinated directly with lab managers to schedule work during periods of low usage. This ensured that lab analysts retained access to critical systems without delays or downtime, preserving operational efficiency.
Targeted Rollout Tracker
A dedicated tracker was created for all in-scope PCs, excluding those not requiring updates. The tracker included only essential information and assigned a clear status to each step of the process, including uninstallation, installation, validation, and documentation, enabling real-time progress monitoring and accountability.
Documentation and Troubleshooting
All actions taken on each PC were documented in alignment with internal QA and regulatory expectations. Troubleshooting steps were standardized and escalated as needed, ensuring consistent resolution and traceability.
RESULTS
Metrics Summary
To evaluate the effectiveness and precision of the antivirus rollout, the following key metrics were tracked throughout the project:
93
Total Number of In-Scope PCs
This represents the full count of laboratory PCs identified as requiring antivirus transition within the project scope
17
Out-of-Scope Identifications
These systems were excluded from the rollout based on predefined criteria, demonstrating the accuracy of the scoping process
0
Days Unprotected
This metric reflects that all systems maintained uninterrupted antivirus protection throughout the transition, ensuring continuous endpoint security
0
Deviations Logged
No deviations from the standard process were recorded, highlighting the consistency, control, and compliance of the rollout
CONCLUSION
A Controlled, Compliant Transition with Zero Downtime
By applying a structured, well-documented approach, the organisation successfully navigate the antivirus transition in a highly regulated lab environment, without compromising system protection or lab productivity
Continuous Protection Maintained: All in-scope PCs were transitioned before the existing antivirus expired, ensuring no gaps in endpoint security.
Full Visibility and Traceability: The use of a centralised tracker and status-based workflow enabled clear oversight of each PC’s progress, supporting audit readiness and internal QA requirements.
Minimal Disruption to Lab Operations: Through proactive scheduling and close coordination with lab managers, the project was delivered without impacting day-to-day lab activities.
Standardised Troubleshooting and Documentation: Issues were resolved efficiently using predefined protocols, and all actions were recorded in line with regulatory expectations.
This project demonstrates how operational IT changes, when executed with precision, planning, and compliance in mind, can be delivered seamlessly in a GxP environment. These advances have boosted security, compliance and reliability, saving $160,000 annually through AV license consolidation. The result was a secure, traceable, and disruption-free rollout that upheld both cybersecurity and regulatory standards.
Gerard Cullen
Informatics Lead, Dublin
4 August 2025